A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice

NCT05254366 · clinicaltrials.gov ↗

COMPLETED

Status

2022

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroscopic and Colonoscopic Sedation

Interventions

DRUG: Remimazolam Tosilate for Injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.